UNSPSC 51101935: Pamaquine

This classification denotes an antimalarial agent with the molecular formula C19H29N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 99QVL5KPSU, chemically known as 1,4-pentanediamine, n1,n1-diethyl-n4-(6-methoxy-8-quinolinyl)- (9ci) but generally known as pamaquine, which bears US NIH Compound Identifier 10290. European Medicines Agency schedules Pamaquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09595MIG. The term PAMAQUINE is an International Non-Proprietary Name.

UNSPSC 51101935 Pamaquine is a Commodity code nominally for a single anti-malarial pharmaceutical, but recent state and local solicitations tagged with this code show no activity for pamaquine itself. Instead, the opportunities reflect procurement of a broader range of pharmaceutical products and medical supplies — naloxone and drug deactivation systems for community health programs, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing, direct-to-manufacturer prescription programs, and first-aid supplies for emergency response. The issuing bodies span county health departments (Seminole County, Florida), state health commissions (Texas HHS), fire departments and municipal purchasing (City of Tampa), and multi-state cooperative purchasing alliances (MMCAP administered by Minnesota Department of Administration). The code shows activity across health, emergency response, and pharmacy benefit contexts rather than a single well-defined product line.

Recent opportunities include an IFB from Seminole County, Florida (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; an RFI from the Texas Health and Human Services Commission (posted April 3, 2026, due April 3, 2026) seeking vendor capabilities for direct-to-manufacturer prescription programs; an ITB from the City of Tampa Purchasing Department (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first-aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount; and an RFP from MMCAP (posted January 20, 2026, due March 26, 2026) to establish contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, with awards effective July 1, 2026. The code shows scattered recent activity in Florida, Texas, and Minnesota through multi-state cooperative purchasing, with no discernible geographic concentration or pattern of repeat issuing bodies under the nominal pamaquine commodity classification.